Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)

Abstract

<jats:title>Abstract</jats:title><jats:p>A novel zoonotic coronavirus outbreak is spreading all over the world. This pandemic disease has now been defined as novel coronavirus disease 2019 (COVID-19), and is sustained by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the current gold standard for the etiological diagnosis of SARS-CoV-2 infection is (real time) reverse transcription polymerase chain reaction (rRT-PCR) on respiratory tract specimens, the diagnostic accuracy of this technique shall be considered a foremost prerequisite. Overall, potential RT-PCR vulnerabilities include general preanalytical issues such as identification problems, inadequate procedures for collection, handling, transport and storage of the swabs, collection of inappropriate or inadequate material (for quality or volume), presence of interfering substances, manual errors, as well as specific aspects such as sample contamination and testing patients receiving antiretroviral therapy. Some analytical problems may also contribute to jeopardize the diagnostic accuracy, including testing outside the diagnostic window, active viral recombination, use of inadequately validated assays, insufficient harmonization, instrument malfunctioning, along with other specific technical issues. Some practical indications can hence be identified for minimizing the risk of diagnostic errors, encompassing the improvement of diagnostic accuracy by combining clinical evidence with results of chest computed tomography (CT) and RT-PCR, interpretation of RT-PCR results according to epidemiologic, clinical and radiological factors, recollection and testing of upper (or lower) respiratory specimens in patients with negative RT-PCR test results and high suspicion or probability of infection, dissemination of clear instructions for specimen (especially swab) collection, management and storage, together with refinement of molecular target(s) and thorough compliance with analytical procedures, including quality assurance.</jats:p>

COVID-19: A promising cure for the global panic

“…These methods can also be compromised due to inadequate sample volume, inaccuracies in methods of testing, not collecting samples at the appropriate time window, and contamination. Similar issues have been identified as potential problems that may diminish the precision of the tests (Lippi et al, 2020). Moreover, these tests are also expensive, hence cheaper alternatives have been developed to track the symptoms of COVID-19 using smart-phone surveillance (Dorigatti et al, 2020).…”

Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks

“…[15] Investigators anticipate false negative test rates are likely to be highest near the beginning and end of the disease spectrum: in asymptomatic, infected patients and convalescing patients. [16,17] Ultimately, COVID-19 positive patients may even elude a two-week quarantine with negative SARS-CoV-2 testing. Second, the virus replicates in the nasal cavity, nasopharynx and oropharynx, which are routine sites of head and neck surgery.…”

Statistical methods for batch screening of input populations by stage and group in COVID-19 nucleic acid testing

“…This method is not only limited to entrying population detection, but also can be used in community poplation detection and close contact population detection [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] .…”